Guilherme Tavares de Arruda

Guilherme Tavares de Arruda

Auto-generated profile, based on publicly available information

Guilherme Tavares de Arruda

Universidade Federal de São Carlos (UFSCAR), Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2022 in Gynecological Endocrinology
Verified
Journal Article
Closed access
GAGuilherme Tavares de Arruda
Guilherme Tavares de Arruda
PDPatricia Driusso
Patricia Driusso
JRJéssica Cordeiro Rodrigues
Jéssica Cordeiro Rodrigues
AGAmanda Garcia de Godoy
Amanda Garcia de Godoy
MAMariana Arias Avila
Mariana Arias Avila
Objective: To evaluate the numerical rating scale (NRS) measurement properties in women with dysmenorrhea. Methods: This was an online clinimetric study. Brazilian women aged over 18 years old with internet access to respond to online instruments were included in the study. We evaluated criterion validity (comparing women with and without dysmenorrhea), construct validity between the NRS and the bodily pain domain of the SF-36, test-retest reliability, and measurement errors (in women with dysmenorrhea). Results: Two hundred thirty-eight women with and 192 without dysmenorrhea participated in the study. For criterion validity, the area under the receiver operating characteristic curve was 0.902 (95%CI, 0.873–0.931), and a cutoff point of 3 was considered to have the best sensitivity (83%) and specificity (86%). For construct validity, the NRS showed a moderate negative correlation with the SF-36 bodily pain domain (r=-0.46; p < 0.001). For test-retest reliability and measurement errors, 105 women whose symptoms did not change between 7 and 10 days of retest, with intraclass correlation coefficient = 0.90, standard error of measurement = 0.97, and smallest detectable change = 2.76 points. Conclusions: The NRS can be considered a valid and reliable patient-reported outcome measure for assessing dysmenorrhea-related pain intensity.

12 March 2021 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
GAGuilherme Tavares de Arruda
Guilherme Tavares de Arruda
THThaise Dos Santos Henrique
Thaise Dos Santos Henrique
JVJaneisa Franck Virtuoso
Janeisa Franck Virtuoso

23 September 2025 in Pain
Verified
Journal Article
Closed access
GAGuilherme Tavares de Arruda
Guilherme Tavares de Arruda
JSJordana da Silva
Jordana da Silva
PDPatricia Driusso
Patricia Driusso
CPCinthuja Pathmanathan
Cinthuja Pathmanathan
SASusan Armijo-Olivo
Susan Armijo-Olivo
MAMariana Arias Avila
Mariana Arias Avila
Dysmenorrhea is menstrual pain of uterine origin that can be classified as primary (PD) or secondary (SD). The worldwide prevalence of dysmenorrhea has been estimated in previous systematic reviews; however, these results are often limited by the focus on specific populations, or the inclusion of studies published only in English. Therefore, we estimated the worldwide prevalence of dysmenorrhea of both PD and SD. In this systematic review, we searched 6 databases for studies reporting the prevalence of dysmenorrhea published between 2000 and 2024, without language restriction. The risk of bias of the included studies was assessed using the Joana Briggs Institute tool. Meta-analysis was conducted in Rstudio. The heterogeneity within meta-analyses was evaluated by I 2 statistics. Subgroup analyses were performed by PD, SD, age group, and study setting to investigate sources of heterogeneity as well. The certainty of evidence was assessed using GRADE modified for prevalence studies. A total of 336 studies were included in this systematic review. Most of them were conducted in Asia (49.4%). The pooled worldwide prevalence of dysmenorrhea, PD, and SD were 71.3% (95% CI 68.7%-73.8%), 73% (95% CI 68%-78%), and 35% (95% CI 19%-56%), respectively. Dysmenorrhea was more prevalent in Central America (89.6%), Sri Lanka (97.7%), among adults (73.3%), and at universities (78.4%). All subgroup analyses showed high heterogeneity (I 2 = 99.5%-100%) with very low certainty of evidence. This high prevalence of dysmenorrhea worldwide highlights the need for healthcare providers and public health organizations to address menstrual pain's global burden.

17 April 2025 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
DAde Arruda
de Arruda
GTGuilherme Tavares
Guilherme Tavares
CTCaroline B. Terwee
Caroline B. Terwee
EEEllen B. M. Elsman
Ellen B. M. Elsman
MAMariana Arias Avila
Mariana Arias Avila
LMLidwine B. Mokkink
Lidwine B. Mokkink

6 July 2022 in European journal of pain
Verified
Journal Article
Closed access
GAGuilherme Tavares de Arruda
Guilherme Tavares de Arruda
PDPatricia Driusso
Patricia Driusso
JRJéssica Cordeiro Rodrigues
Jéssica Cordeiro Rodrigues
AGAmanda Garcia de Godoy
Amanda Garcia de Godoy
ADAdriana Degani
Adriana Degani
MAMariana Arias Avila
Mariana Arias Avila

16 May 2022 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
GAGuilherme Tavares de Arruda
Guilherme Tavares de Arruda
DADalton Francisco de Andrade
Dalton Francisco de Andrade
JVJaneisa Franck Virtuoso
Janeisa Franck Virtuoso
Purpose: To evaluate the internal structure (structural validity and internal consistency) and propose a classification for the distress caused by the presence of pelvic floor dysfunction (PFD) symptoms based on the total score of the Pelvic Floor Distress Inventory (PFDI-20). Methods: Cross-sectional study conducted with Brazilian women over 18 years of age. Exploratory and confirmatory factor analysis were performed with Parallel Analysis and to test three models to compare them with the Root Mean Square Error of Approximation (RMSEA) and Comparative Fit Index (CFI). Internal consistency was calculated using Cronbach's alpha. Partial credit model (PCM) was performed to classify the total score of the PFDI-20. Results: Data from 237 women (49.62 ± 16.95 years) were analyzed. The one-dimensional structure had 43.74% of the explained variance with α = 0.929. The one-dimensional model was the most appropriate (CFI = 0.987 and RMSEA = 0.022). The total PFDI-20 score was classified as the absence of symptoms (score zero), symptoms with mild distress (1 to 15 points), symptoms with moderate distress (16 to 34 points), and symptoms with severe distress (35 to 40 points). Conclusion: The PFDI-20 has an one-dimensional structure and the distress caused by the presence of PFD symptoms can be classified as mild, moderate and severe. Health professionals and future studies can use our classification to facilitate the understanding of the patient's health status and to obtain other analyses on the severity of the distress of the symptoms of PFD.